Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Crit Care Clin ; 40(2): 367-390, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38432701

ABSTRACT

Acute respiratory failure is commonly encountered in severe acute brain injury due to a multitude of factors related to the sequelae of the primary injury. The interaction between pulmonary and neurologic systems in this population is complex, often with competing priorities. Many treatment modalities for acute respiratory failure can result in deleterious effects on cerebral physiology, and secondary brain injury due to elevations in intracranial pressure or impaired cerebral perfusion. High-quality literature is lacking to guide clinical decision-making in this population, and deliberate considerations of individual patient factors must be considered to optimize each patient's care.


Subject(s)
Brain Injuries , Respiratory Distress Syndrome , Respiratory Insufficiency , Humans , Brain Injuries/complications , Brain Injuries/therapy , Disease Progression , Respiratory Insufficiency/etiology , Respiratory Insufficiency/therapy
2.
Pharmacol Ther ; 194: 222-254, 2019 02.
Article in English | MEDLINE | ID: mdl-30291908

ABSTRACT

The neurotransmitter acetylcholine (ACh) acts as an autocrine growth factor for human lung cancer. Several lines of evidence show that lung cancer cells express all of the proteins required for the uptake of choline (choline transporter 1, choline transporter-like proteins) synthesis of ACh (choline acetyltransferase, carnitine acetyltransferase), transport of ACh (vesicular acetylcholine transport, OCTs, OCTNs) and degradation of ACh (acetylcholinesterase, butyrylcholinesterase). The released ACh binds back to nicotinic (nAChRs) and muscarinic receptors on lung cancer cells to accelerate their proliferation, migration and invasion. Out of all components of the cholinergic pathway, the nAChR-signaling has been studied the most intensely. The reason for this trend is due to genome-wide data studies showing that nicotinic receptor subtypes are involved in lung cancer risk, the relationship between cigarette smoke and lung cancer risk as well as the rising popularity of electronic cigarettes considered by many as a "safe" alternative to smoking. There are a small number of articles which review the contribution of the other cholinergic proteins in the pathophysiology of lung cancer. The primary objective of this review article is to discuss the function of the acetylcholine-signaling proteins in the progression of lung cancer. The investigation of the role of cholinergic network in lung cancer will pave the way to novel molecular targets and drugs in this lethal malignancy.


Subject(s)
Acetylcholine/metabolism , Lung Neoplasms/metabolism , Adaptor Proteins, Signal Transducing/metabolism , Animals , Antigens, Ly/metabolism , Cholinesterases/metabolism , Disease Progression , Humans , Lung Neoplasms/pathology , Membrane Transport Proteins/metabolism , Receptors, Muscarinic/metabolism , Receptors, Nicotinic/metabolism , Signal Transduction , Urokinase-Type Plasminogen Activator/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...